A view on imaging in drug research and development for respiratory diseases.
about
Targeting and in vivo imaging of non-small-cell lung cancer using nebulized multimodal contrast agents.Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology.Orotracheal administration of contrast agents: a new protocol for brain tumor targeting.Orotracheal manganese-enhanced MRI (MEMRI): An effective approach for lung tumor detection.Three-dimensional accurate detection of lung emphysema in rats using ultra-short and zero echo time MRI.Bleomycin-induced lung injury in mice investigated by MRI: model assessment for target analysis.
P2860
A view on imaging in drug research and development for respiratory diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A view on imaging in drug research and development for respiratory diseases.
@en
A view on imaging in drug research and development for respiratory diseases.
@nl
type
label
A view on imaging in drug research and development for respiratory diseases.
@en
A view on imaging in drug research and development for respiratory diseases.
@nl
prefLabel
A view on imaging in drug research and development for respiratory diseases.
@en
A view on imaging in drug research and development for respiratory diseases.
@nl
P356
P1476
A view on imaging in drug research and development for respiratory diseases.
@en
P2093
Cees J A van Echteld
Nicolau Beckmann
P304
P356
10.1124/JPET.110.172635
P407
P577
2011-02-11T00:00:00Z